Search Within

Howard Scher

Formats
  1. Journal Article (626)
  2. Meeting Abstract (463)
  3. Book Section (13)
  4. Conference Paper (11)
  5. Editorial (7)
  6. Review (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Research Letter (2)
Groups
  1. Department of Medicine (1133)
  2. Genitourinary Oncology Service (1133)
  3. Solid Tumor Oncology Division (1133)
  4. GSK Faculty (305)
  5. Sloan Kettering Institute Faculty (249)
  6. Department of Pathology and Laboratory Medicine (241)

More Groups

People
  1. Michael Morris (217)
  2. Susan Slovin (140)
  3. Dana Rathkopf (133)
  4. Daniel Danila (112)
  5. Steven Larson (110)
  6. Victor Reuter (97)

More People

Years
  1. 2025 (11)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (25)
  5. 2021 (19)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (328)
  2. Clinical Cancer Research (85)
  3. Cancer Research (54)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (47)
  5. Journal of Urology (36)
  6. European Urology (35)

More Publications

Publishers
  1. American Society of Clinical Oncology (335)
  2. American Association for Cancer Research (197)
  3. Elsevier Science, Inc. (119)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (58)
  6. Oxford University Press (47)

More Publishers

Results (1133)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pelvic exenteration in patients with nonmetastatic, locally advanced castration-resistant prostate cancer
    Meeting Abstract

    Donahue, T. F.; Morris, M. J.; Hilton, W. M.; Scher, H. I.; Bochner, B. H.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Dittamore, R.; Louw, J.; Krupa, R.; Anand, A.; Danila, D. C.; Arslan, Z.; Bales, N.; Marrinucci, D.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Characterization of immune-related adverse events (irAEs) in a phase 3 trial of ipilimumab (Ipi) versus placebo (Pbo) in post-docetaxel mCRPC
    Meeting Abstract

    Beer, T. M.; Logothetis, C.; Gerritsen, W. R.; Kwon, E. D.; Scher, H. I.; Bossi, A.; Van Den Eertwegh, A. J. M.; Drake, C. G.; McHenry, B.; Liu, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with prostate cancer and parenchymal brain metastases (PBM)
    Meeting Abstract

    Bambury, R. M.; Hatzoglou, V.; Curtis, K. R.; Patel, G. V.; Scher, H. I.; Young, R. J.; Morris, M. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Anand, A.; Krupa, R.; Louw, J.; Arslan, Z.; Dittamore, R.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival
    Journal Article

    Danila, D. C.; Anand, A.; Schultz, N.; Heller, G.; Wan, M.; Sung, C. C.; Dai, C.; Khanin, R.; Fleisher, M.; Lilja, H.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • Bone metastases in castration-resistant prostate cancer: Associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival
    Journal Article

    Vargas, H. A.; Wassberg, C.; Fox, J. J.; Wibmer, A.; Goldman, D. A.; Kuk, D.; Gonen, M.; Larson, S. M.; Morris, M. J.; Scher, H. I.; more...
    Radiology (2014)

    Fulltext@MSK | Save
  • Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial
    Journal Article

    Sternberg, C. N.; de Bono, J. S.; Chi, K. N.; Fizazi, K.; Mulders, P.; Cerbone, L.; Hirmand, M.; Forer, D.; Scher, H. I.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer
    Journal Article

    Goodman, O. B.; Flaig, T. W.; Molina, A.; Mulders, P. F. A.; Fizazi, K.; Suttmann, H.; Li, J.; Kheoh, T.; de Bono, J. S.; Scher, H. I.
    Prostate Cancer and Prostatic Diseases (2014)

    Fulltext@MSK | Save
  • Outcomes in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial
    Meeting Abstract

    Sternberg, C. N.; De Bono, J. S.; Chi, K. N.; Fizazi, K.; Mulders, P.; Hirmand, M.; Forer, D.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save